OREM, UTAH, USA -April 13, 2010- Aribex, Inc. announced today the settlement of a patent case involving Sigma Biomedics, Inc., Dentalaire Products International, and DigiMed Co., Ltd. The case was brought in the U.S. District Court for the District of Utah in October, 2009 alleging infringement of U.S. Patent No. 7,496,178 for a hand held x-ray device. None of the parties admitted any liability.
OREM, UTAH, USA -April 13, 2010- Aribex, Inc. announced today the settlement of a patent case involving Sigma Biomedics, Inc., Dentalaire Products International, and DigiMed Co., Ltd. The case was brought in the U.S. District Court for the District of Utah in October, 2009 alleging infringement of U.S. Patent No. 7,496,178 for a hand held x-ray device. None of the parties admitted any liability.
Under the terms of the settlement agreement, Sigma Biomedics, Dentalaire Products International and Digimed Co. have discontinued the distribution of the Bio-Ray PROX and similar hand-held x-ray devices within the United States. The other terms of the settlement agreement are confidential. Commenting on the settlement, Aribex President and CEO, Dr. Clark Turner, PhD, said. "We are pleased that the parties have chosen to resolve this matter amicably. We believe that this resolution is positive for Aribex, our customers, our partners, and the overall x-ray industry."
About Aribex
Aribex Inc. is a privately held company headquartered in Orem, Utah. Aribex designs, develops and manufactures products in the x-ray radiography fields. Aribex's flagship products are NOMAD and NOMAD Pro handheld x-ray systems providing battery powered devices in dentistry and other x-ray imaging solutions in veterinary, medical, industrial, and security applications. For more information, please visit Aribex's web site: aribex.com.
How Dentists Can Help Patients Navigate Unforeseen Dental Care
December 12th 2024Practices must equip patients with treatment information and discuss potential financing options before unexpected dental treatments become too big of an obstacle and to help them avoid the risk of more costly and invasive procedures in the future.